首页>
外国专利>
PHARMACEUTICAL COMPOSITION FOR INHIBITING RESISTANCE AGAINST ANTICANCER DRUGS OF PATIENT SUFFERING FROM OVARIAN CANCER COMPRISING NAG-1 INHIBITOR AS ACTIVE INGREDIENT
PHARMACEUTICAL COMPOSITION FOR INHIBITING RESISTANCE AGAINST ANTICANCER DRUGS OF PATIENT SUFFERING FROM OVARIAN CANCER COMPRISING NAG-1 INHIBITOR AS ACTIVE INGREDIENT
展开▼
机译:包含抗NAG-1抑制剂作为活性成分的卵巢癌患者的抗药性药物的药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
A pharmaceutical composition includes an NAG-1 inhibitor as an active ingredient for inhibiting resistance against an anticancer drug of an ovarian cancer patient and a method of diagnosing prognosis of resistance against an anticancer drug of an ovarian cancer patient by using the NAG-1 inhibitor. It is found by controlling NAG-1 protein that NAG-1, which is overexpressed in an ovarian cancer patient and in an ovarian cancer stem cell having resistance against an anticancer drug, plays a key role in a chronic inflammatory reaction and resistance against an anticancer drug, and in this regard, NAG-1 can be used as a target gene for effective tumor therapy.
展开▼